Jakarta, August 27, 2025 – For the first time ever, Indonesia became the stage for a series of world-class medical aesthetic treatments at the Now You See PYFAESTHETIC Summit 2025, an international scientific seminar that blended innovation, education, and collaboration into a single event. Held at The Dome Spark, Jakarta, on August 2, the summit served as a meeting point for enthusiastic dermatologists and aesthetic doctors eager to stay updated on the latest scientific advancements in aesthetics. This event is a clear testament to the commitment of PYFAESTHETIC, a business unit under PT Pyridam Farma Tbk (PYFA), to providing medical aesthetic products and services that meet global standards.
With the global medical aesthetics market projected to reach USD 25.9 billion by 2028, the Asia Pacific region—including Indonesia—is experiencing a surge in demand for safe, effective, and innovative services. As a strategic response to this opportunity, PYFAESTHETIC introduced a range of cutting-edge treatments. These include a high-purity micro spicule + BHA for acne-prone skin, hyaluronic acid for hydration and facial volume enhancement, Synthetic Small Extracellular Vesicles for regenerative skin care, a combination of Sodium DNA + Sodium Hyaluronate for hydration and skin regeneration, and PLACL thread lifts for collagen stimulation. This diverse portfolio offers doctors a wide selection of options to provide the best possible care for their patients.
In her welcome speech, Wila Lesthia Kharisma, Head of Marketing at PYFAESTHETIC, emphasized that the company will continue to provide innovative products with a science-based understanding of aesthetics. “In addition to bringing technology, we are committed to building a learning platform to advance the aesthetics industry throughout Indonesia. With the Now You See PYFAESTHETIC Summit 2025, we hope this event becomes a meaningful space for learning, inspiration, and collaboration so that we can continue to raise the standards of aesthetic care for our professionals and community,” she said.
The PYFAESTHETIC Summit 2025 was attended by over 70 dermatology and aesthetics specialists and featured a lineup of prominent international and national speakers. They included: Dr. Radu; Dr. Hari Darmawan, Sp.DVE; Dr. Angelia Ongko Prabowo, M.Biomed (AAM); Dr. Theressia Handayani, M.Biomed (AAM); Dr. Stanley Setiawan, Sp.DVE, FINSDV, FAADV; Dr. Anita Anggoro, Dipl.AAAM; Dr. Yuly Lie Jaya, M.Biomed (AAM); Dr. Almond Wibowo, M.Biomed (AAM); Dr. Feidriwan, M.Biomed (AAM); Dr. Achmad Yudha Pranata, Sp.DVE; Dr. Mathelda Weni Haryanti, M.Kes (AAM); Dr. Felix Kusmana, M.Biomed (AAM); Dr. Irfan Prasetya Yoga; Dr. Devy, M.Biomed (AAM), Dipl.AAAM; Dr. Kristian Sanjaya, S.H., M.Biomed (AAM); Dr. Leroy Lucano, M.Biomed (AAM); Dr. Christian Jevon, Dipl.AAAM; Prof. Roberto Amore (Medical & Representative Love Cosmedical); and Rosa Kwon (Chief Executive Officer, Bellegen).
The intensive discussions were led by two experienced moderators, Dr. Kardiana Dewi, Sp.DVE, FINSDV, and Dr. Christian Jevon, Dipl.AAAM, who also served as speakers. Both successfully created a dynamic, interactive, and insightful discussion flow.
For PYFAESTHETIC, innovation doesn’t stop at just providing top-tier products from around the world. The company also solidifies its role as a provider of a continuous learning platform, ensuring Indonesian doctors always stay at the forefront of medical aesthetic science and technology.
The enthusiasm of the participants was evident. Dr. Rara Juwita remarked, “This event was very insightful and refreshing. There are many materials and journals that I can directly apply to my daily practice. I feel more confident with the science-based approach that PYFAESTHETIC promotes. I hope that in the future, PYFAESTHETIC will not only bring in more excellent products but also continue to provide learning platforms like this event.”
Meanwhile, Dr. Dana, M.Biomed (AAM), added, “This summit is not just a seminar but a serious and high-class learning platform. For me, the PYFAESTHETIC Summit is the one and only in Indonesia. I really appreciate how PYFAESTHETIC brings together various ideas from both local and international experts on one high-quality stage.”
With the Now You See PYFAESTHETIC Summit 2025, the Indonesian medical aesthetics industry now has a direct window into global treatment trends and insights, opening a new era for quality, safe, and internationally standardized aesthetic services.
About PYFA
PT Pyridam Farma Tbk (“PYFA”), known by the brand PYFAGROUP, is a public company in the pharmaceutical sector listed on the Indonesia Stock Exchange (Stock Code: PYFA). PYFA’s business units include prescription drugs in various forms, such as tablets, capsules, creams, and injections. PYFA is the controlling shareholder of several subsidiaries, including PT Holi Pharma in Cimahi, West Java; PT Ethica Industri Farmasi in Cikarang, West Java; and Probiotec Pty Ltd in Australia.
About PYFAESTHETIC
PYFAESTHETIC is a business unit of PYFA that focuses on dermatology and aesthetics. It provides a variety of international beauty products registered with the BPOM (Indonesian Food and Drug Authority), such as skincare, fillers, and beauty devices for professional practitioners. Beyond product distribution, PYFAESTHETIC also actively organizes professional training, including cadaver training abroad. Through its approach based on quality, education, and collaboration, PYFAESTHETIC also serves as a strategic partner for global beauty brands to enter the Indonesian market and support the advancement of the aesthetics industry in Southeast Asia.
Media Relations
Leilanie Nadia Kusuma
Website: www.pyfa.co.id
Email: corcomm@pyfa.co.id
